Table 1

Demographic and laboratory data of survivors and non-survivors of COVID-19

All patientsSurvivorsNon-survivors
MedianIQR% Path valuesMedianIQR% Path valuesMedianIQR% Path values
Age (years)*6522.2562.5217912.5
Biochemistry
 Glucose (mmol/L)5.881.74455.881.5442.66.833.960
 Creatinine (µmol/L)*88.4235.3731.779.5835.3728.297.2635.3753.3
 Sodium (mmol/L)13857.813857.41384.810
 Potassium (mmol/L)3.80.78.73.80.77.440.816.7
 Albumin (g/L)*31771.531767.727993.1
 ALT (U/L)3129.562.4303063.53833.555.2
 LDH (U/L)*300168.581.229414978.1407156100
 CRP (mg/L)*5611385.24510483.98514193.3
Haematology
 White blood cells (109/L)6.94.314.26.84.314.98.4410
 N:L ratio4.24.572.54.13.770.27.211.586.7
 Neutrophils (109/L)*53.823.44.73.521.374.836.7
 Lymphocytes (109/L)1.10.8671.10.865.40.9176.7
 Monocytes (109/L)0.50.415.10.50.416.50.40.36.7
 Eosinophils (109/L)0.10.74.60.10.74.800.23.3
 Basophils (109/L)0.10.1000.10000
 Red blood cells (106/L)4.60.722.94.60.721.84.60.930
 Haemoglobin (g/L)1397828.41402127.11362336.7
 Haematocrit0.40.05390.40.0635.60.40.0660
 Platelets (109/L)19110640.8191109.320.2185104.320
Arterial blood gas
 pH7.40.136.77.40.141.37.40.139.7
 PCO2 (mm Hg)34.58.253.634.88.553.933.36.851.7
 PO2 (mm Hg)80.335.766.380.739.565.370.825.772.4
 PO2:FIO2 ratio*378.5171.372.738417675.933319453.6
 satO2:FIO2 ratio*456.730.489.6457.923.890.2437.1128.985.7
Coagulation
 PT (s)*13269.813266.514790
 aPTT (s)30.9514.530.94.51230.65.930
 D-dimer (ng/mL)*636104060.456677256.411071049.885.7
  • Glucose (3.89–6.11 mmol/L); creatinine (men: 61.89–106.1 µmol/L, women: 44.21–79.58 µmol/L); sodium (135–145 mmol/L); potassium (3.5–4.5 mmol/L); albumin (34–52 g/L); ALT (0–33 U/L); LDH (135–214 U/L); CRP (<5 mg/L); white blood cells (3.5–12.0×109 cells/L); neutrophils (1.5–7.5×109 cells/L); lymphocytes (1.3–4.0×109 cells/L); monocytes (0.2–1.0×109 cells/L); eosinophils (0.0–0.2×109 cells/L); basophils (0.0–0.5×109 cells/L); red blood cells (4.3–5.6×106 cells/L); haemoglobin (men 135–175 g/L, women 120–155 g/L); haematocrit (men 41%–53%, women 36%–46%); platelets (140–450 109/L); pH (7.32–7.42); PCO2 (38.0–52.0 mm Hg); PO2 (24.0–48.0 mm Hg); PT (9.4–12.5 s); aPTT (24–37 s); D-dimer (0–500 ng/mL).

  • *When comparing survivors with non-survivors p<0.05.

  • ALT, alanine aminotransferase; aPTT, activated partial thromboplastin time; CRP, C reactive protein; L, lymphocyte; LDH, lactate dehydrogenase; N, neutrophil; PT, prothrombin time.